Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 781800 of 20,252 grants

Active NON-SBIR/STTR RPGS
Oncolytic HSV Immunovirotherapy for brain tumors
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2029

Glioblastoma (GBM) is a fatal cancer of the brain showing little change in survival over decades of therapeutic trials. Development of oncolytic viruses (OV) is iterative and exten...

$6.27M
USD
Active NON-SBIR/STTR RPGS
Novel applications and translation of [18F]hGTS13, a system xc- specific radiopharmaceutical
NATIONAL CANCER INSTITUTE Stanford University United States 2024 – 2029

ABSTRACT. Ferroptosis is a form of regulated cell death defined by the iron-dependent accumulation of membrane lipid peroxides that results in oxidative damage and plasma membrane...

$4.11M
USD
Active NON-SBIR/STTR RPGS
Unveiling the Role of UBE2J1 as the E2 Ubiquitin Conjugating Enzyme in Androgen Receptor Degradation
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2024 – 2029

PROJECT SUMMARY Despite the significant clinical success of AR-targeted therapies in the management of prostate cancer (PCa), resistance to these treatments remains a significant c...

$4.08M
USD
Active TRAINING, INDIVIDUAL
What is the mechanism by which a gene essential for Rhabdoid tumor viability regulates Chromatin function?
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2024 – 2027

Project Summary Large-scale cancer genome sequencing projects have highlighted the frequency of mutation in chromatin modifiers in cancer. Mutations in genes encoding the members o...

$742.8K
USD
Active TRAINING, INDIVIDUAL
Integrating highly multiplexed immunofluorescence with label-free 2D hyperspectral chemical imaging to interrogate the colorectal cancer tumor-invasive front
NATIONAL CANCER INSTITUTE Stanford University United States 2024 – 2027

Project Summary/Abstract Colorectal cancer (CRC) is the second most common cause of cancer-related death in the United States. Despite advances in both diagnostic and therapy, a la...

$742.8K
USD
Completed SBIR-STTR RPGS
Non-invasive cancer detection and residual disease monitoring by cell-free nucleic acid from saliva
NATIONAL CANCER INSTITUTE Nord Bio Inc United States 2024 – 2025

Cancer is one of the leading causes of death globally and detection, continuous monitoring and effective treatment are critical for improving patient outcomes. Currently, cancer di...

$2.96M
USD
Active NON-SBIR/STTR RPGS
Genetic predisposition and misdiagnosis of cancer in All of Us participants
NATIONAL CANCER INSTITUTE Brigham Young University United States 2024 – 2027

SUMMARY/ABSTRACT The National Cancer Institute estimates ~40% of persons in the United States will be diagnosed with cancer at some point in their lives (https://www.cancer.gov). W...

$4.34M
USD
Active NON-SBIR/STTR RPGS
Translating glycans into biomarkers
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2024 – 2029

Alterations in glycosylation have been associated with the development and progression of many types of cancers and other chronic and acute diseases. Structural glycan analysis on...

$5.96M
USD
Active NON-SBIR/STTR RPGS
Investigating mechanisms of tumor plasticity in human bladder cancer
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2024 – 2029

Project Summary/Abstract The progression of bladder cancer from non-invasive to muscle invasive disease represents a critical step that is associated with adverse clinical outcomes...

$4.77M
USD
Active NON-SBIR/STTR RPGS
Interrogating the relationship between translational dynamics and non-canonical antigen presentation in lung cancer
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2024 – 2029

ABSTRACT Antigen presentation is a fundamental component of cancer immunity. The primary cytotoxic effectors of cancer immunity are CD8+ T cells, which recognize peptide antigens p...

$4.85M
USD
Active NON-SBIR/STTR RPGS
Epidemiologic study of microplastic pollution in bronchoalveolar lavage fluid and its association with lung cancer
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2024 – 2026

ABSTRACT An estimated 400 metric tons of plastic are produced each year worldwide and less than 10% is recycled. Microplastics (MPs) defined as particles

$4.26M
USD
Active NON-SBIR/STTR RPGS
WASp signaling in T-cell lymphomas
NATIONAL CANCER INSTITUTE University of Illinois At Chicago United States 2024 – 2029

ABSTRACT Title: WASp signaling in T-cell lymphomas Peripheral T-cell lymphomas (PTCL) are aggressive disorders, with less than 50% overall survival after 2-3-years of diagnosis. Th...

$4.87M
USD
Active NON-SBIR/STTR RPGS
Targeting FGFR Alterations in Gastroesophageal Cancer
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2024 – 2029

PROJECT SUMMARY Gastroesophageal adenocarcinoma (GEA) is the 4th leading cause of cancer deaths worldwide with a median survival of 6.2 months for patients who present with metasta...

$7.16M
USD
Active NON-SBIR/STTR RPGS
ATG16L1 isoforms and CRC health disparities
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2024 – 2026

Compared to non-Hispanic Whites (NHW), African Americans (AAs) are 20% more likely to get colorectal cancer (CRC) and 40% more likely to die from CRC. The negative impacts of healt...

$3.99M
USD
Active TRAINING, INDIVIDUAL
Deconvoluting the contributions of the IFNy pathway components to lung TME and tumor immunity
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2024 – 2026

Project Summary The approval of anti-PD1/PD-L1 and anti-CTLA immune checkpoint blockade (ICB) therapies for those with non- small cell lung cancer (NSCLC) has demonstrated that imm...

$539.7K
USD
Active TRAINING, INDIVIDUAL
Characterizing DC-specific mechanisms of LNP immunogenicity to enhance LNP-based anti-tumor therapies
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2024 – 2027

PROJECT SUMMARY In the first 6 months after COVID-19 vaccine approval, 3.4 billion doses were administered globally, potentially saving 7.2 million lives. Lipid nanoparticle (LNP)-...

$427.2K
USD
Active NON-SBIR/STTR RPGS
Circulating tumor cell profiling for genomic contributors to racial disparity in metastatic prostate cancer
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT In the United States, prostate cancer is the most prevalent malignancy, with disproportionately higher incidence and mortality rates among black men than t...

$1.56M
USD
Active NON-SBIR/STTR RPGS
A novel role for EZH2 in PARP regulation and PARPi-resistance in prostate cancer
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2024 – 2029

Prostate cancer is the leading cause of cancer-related deaths in American men. It is estimated that each year more than 180,000 new prostate cancer patients will be diagnosed, and...

$5.82M
USD
Active NON-SBIR/STTR RPGS
Elucidating resistance mechanisms and enhancing response to immune checkpoint blockade in central nervous system metastases from breast cancer
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2029

PROJECT SUMMARY Metastases to the central nervous system (CNS) are a common complication of breast cancer. Prognosis is typically on the order of a few months. Immunotherapies have...

$7.01M
USD
Completed OTHER RESEARCH-RELATED
Systems Approaches to Cancer Biology Meeting
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2024 – 2025

SUMMARY The Systems Approaches to Cancer Biology (SACB) meeting aims to bring together scientific leaders and early-stage investigators in Cancer Systems Biology to build and foste...

$254K
USD